Xingaotopi
Pudong
About Xingaotopi
Xingaotopi focuses on the innovative development of novel therapeutic drugs for sensorineural hearing loss, aiming to restore auditory function and improve quality of life through advanced biomedical research and cutting-edge treatment technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $14.3M
- Funding stage: Seed
- Last round: Seed (Jan 2026)
- Website: otoviatx.com
- Phone: +86 021-33670678
Industries & Categories
Health Care, Medical Device, Therapeutics
Canonical: https://fsome.com/organization/xingaotopi-38780 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.